Arab Pharmaceuticals ADCI
العربية للأدوية والصناعات الكيماوية (أدكو)
Health Care & PharmaceuticalsEgyptian Exchange
272.00 EGP
-0.48%
Close of Thu 12 Nov 2026
- Market value
- EGP 3.24bn
- Highest and lowest close in a year
- 146.67 – 341.08
- Shares traded in the session
- 6,463
A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.
About the company
Arab Pharmaceuticals (ADCO) is a Cairo-based company operating in the pharmaceuticals, biotechnology, and life sciences sector, with a primary focus on pharmaceuticals. Established in July 1991 and incorporated on 20 July 1991, it has been listed on the Egyptian Exchange since February 1996. The company is controlled by the Holding Co for Pharmaceuticals with a 60.3% stake, and it holds a 0.86% stake in Arab Company for Gelatin and Pharmaceutical Products.
Its record at the exchange
Across 833 filings between 2010 and 2026, the company logged its most active year in 2014 with 67 disclosures. It recorded 65 periods of reported profit or loss from 2013 to 2026 with zero loss-making periods. Net results ranged from a low of 1 million EGP in Q3 2014 to a peak of 228 million EGP in FY 2025. Trading was suspended 4 times and resumed 5 times, alongside 3 capital-increase filings.
Its latest filings at the exchange
- Board decisionsArab Pharmaceuticals (ADCI.CA) - Board of Directors' Decisions
- Arab Pharmaceuticals (ADCI.CA) Declares Cash Dividends
- Release from Arab Pharmaceuticals (ADCI.CA) Concerning the Company's Regulatory Framework
- Shareholders' meetingArab Pharmaceuticals (ADCI.CA) - AGM Minutes (before Certification)
- Shareholders' meetingArab Pharmaceuticals (ADCI.CA) - AGM Resolutions
- Board decisionsArab Pharmaceuticals (ADCI.CA) - Decisions of the BoD Meeting
- Board decisionsArab Pharmaceuticals (ADCI.CA) - Decisions of the BoD Meeting
- Release from Arab Pharmaceuticals (ADCI.CA) Concerning Amendments in the Executive Management
Insider trades in the exchange’s bulletin
As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.
- Insider / Board Bought530 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought1,435 (0.01% of the company)Bulletin ↗
- Insider / Board Bought330 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought455 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought1,079 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought1,171 (less than 0.01% of the company)Bulletin ↗
- Insider / Board Bought2,000 (0.02% of the company)Bulletin ↗
- Insider / Board Sold3,000 (0.03% of the company)Bulletin ↗
- Insider / Board Bought2,000 (0.02% of the company)Bulletin ↗
- Insider / Board Sold1,000 (less than 0.01% of the company)Bulletin ↗
Other companies in Health Care & Pharmaceuticals
- GlaxoSmithKline S.A.E. BIOC
- Cleopatra Hospital Company CLHO
- Egyptian International Pharmaceutical Industries Co. PHAR
- El-Nile Co. for Pharmaceuticals & Chemical Industries NIPH
- Alexandria New Medical Center Co. AMES
- Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda RMDA
- Ibnsina Pharma ISPH
- Minapharm Pharmaceuticals MIPH
- Kahira Pharmaceuticals & Chemical Industries Co. CPCI
- Memphis Pharmaceutical & Chemical Industries MPCI
- Alexandria Company for Pharmaceuticals and Chemical Industries AXPH
- Nozha International Hospital NINH
Page updated with the data of 15 Nov 2026.